Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1219 ARTÍCULOS , VIENDO DEL 691 AL 705

Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition

Pontecorvo MJ, Devous MD Sr, Navitsky M, Lu M, Salloway S, Schaerf FW, Jennings D, Arora AK, McGeehan A, Lim NC, Xiong H, Joshi AD, Siderowf A, Mintun MA; 18F-AV-1451-A05 investigators.

Brain. 2017 Mar 1;140(3):748-763. doi: 10.1093/brain/aww334.

Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population

Claus JJ, Staekenborg SS, Holl DC, Roorda JJ, Schuur J, Koster P, Tielkes CEM, Scheltens P.

Eur Radiol. 2017 Aug;27(8):3147-3155. doi: 10.1007/s00330-016-4726-3. Epub 2017 Jan 12.

Typical and atypical appearance of early-onset Alzheimer's disease: A clinical, neuroimaging and neuropathological study

Kawakatsu S, Kobayashi R, Hayashi H.

Neuropathology. 2017 Apr;37(2):150-173. doi: 10.1111/neup.12364. Epub 2017 Jan 17.

Review of Decision-Making in Game Tasks in Elderly Participants with Alzheimer Disease and Mild Cognitive Impairment

de Siqueira AS, Yokomizo JE, Jacob-Filho W, Yassuda MS, Aprahamian I.

Dement Geriatr Cogn Disord. 2017;43(1-2):81-88. doi: 10.1159/000455120. Epub 2017 Jan 18.

Optical Coherence Tomography Reveals Retinal Neuroaxonal Thinning in Frontotemporal Dementia as in Alzheimer's Disease

Ferrari L, Huang SC, Magnani G, Ambrosi A, Comi G, Leocani L.

J Alzheimers Dis. 2017;56(3):1101-1107. doi: 10.3233/JAD-160886.

Nonpharmacological Strategies for Patients With Early-Stage Dementia or Mild Cognitive Impairment: A 10-Year Update

Anderson JG, Lopez RP, Rose KM, Specht JK.

Res Gerontol Nurs. 2017 Jan 1;10(1):5-11. doi: 10.3928/19404921-20161209-05.

Association of Delirium With Cognitive Decline in Late Life: A Neuropathologic Study of 3 Population-Based Cohort Studies

Davis DH, Muniz-Terrera G, Keage HA, Stephan BC, Fleming J, Ince PG, Matthews FE, Cunningham C, Ely EW, MacLullich AM, Brayne C; Epidemiological Clinicopathological Studies in Europe (EClipSE) Collaborative Members.

JAMA Psychiatry. 2017 Mar 1;74(3):244-251. doi: 10.1001/jamapsychiatry.2016.3423.

The Tat-Aβ1-6A2V(D) peptide against AD synaptopathy

Buccarello L, Borsello T.

Oncotarget. 2017 Feb 14;8(7):10773-10774. doi: 10.18632/oncotarget.14604.

Vitamin E for Alzheimer's dementia and mild cognitive impairment

Farina N, Llewellyn D, Isaac MG, Tabet N.

Cochrane Database Syst Rev. 2017 Jan 27;1(1):CD002854. doi: 10.1002/14651858.CD002854.pub4.

Social network and cognitive functioning in old age : Self-efficacy as a mediator?

Fankhauser S, Maercker A, Forstmeier S.

Z Gerontol Geriatr. 2017 Feb;50(2):123-131. doi: 10.1007/s00391-016-1178-y. Epub 2017 Jan 27.

Alzheimer's disease: time to focus on the brain, not just molecules

Husain M.

Brain. 2017 Feb;140(2):251-253. doi: 10.1093/brain/aww353.

Italians do it worse. Montreal Cognitive Assessment (MoCA) optimal cut-off scores for people with probable Alzheimer's disease and with probable cognitive impairment

Bosco A, Spano G, Caffò AO, Lopez A, Grattagliano I, Saracino G, Pinto K, Hoogeveen F, Lancioni GE.

Aging Clin Exp Res. 2017 Dec;29(6):1113-1120. doi: 10.1007/s40520-017-0727-6. Epub 2017 Feb 2.

The Visual Association Test-Extended: a cross-sectional study of the performance validity measures

Meyer SR, de Jonghe JF, Schmand B, Ponds RW.

Clin Neuropsychol. 2017 May;31(4):798-813. doi: 10.1080/13854046.2017.1280181. Epub 2017 Feb 3.

A Multi-Cohort Study of ApoE ɛ4 and Amyloid-β Effects on the Hippocampus in Alzheimer's Disease

Khan W, Giampietro V, Banaschewski T, Barker GJ, Bokde AL, Büchel C, Conrod P, Flor H, Frouin V, Garavan H, Gowland P, Heinz A, Ittermann B, Lemaître H, Nees F, Paus T, Pausova Z, Rietschel M, Smolka MN, Ströhle A, Gallinat J, Vellas B, Soininen H, Kloszewska I, Tsolaki M, Mecocci P, Spenger C, Villemagne VL, Masters CL, Muehlboeck JS, Bäckman L, Fratiglioni L, Kalpouzos G, Wahlund LO, Schumann G, Lovestone S, Williams SC, Westman E, Simmons A; Alzheimer–s Disease Neuroimaging Initiative; AddNeuroMed Consortium, Australian, Imaging, Biomarkers, and Lifestyle Study Research Group; IMAGEN consortium.

J Alzheimers Dis. 2017;56(3):1159-1174. doi: 10.3233/JAD-161097.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias